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Superparamagnetic Fe3O4-
PEG2K-FA@Ce6 Nanoprobes for 
in Vivo Dual-mode Imaging and 
Targeted Photodynamic Therapy
Ting Yin1, Peng Huang1, Guo Gao1, Joseph G. Shapter2, Yulan Shen3, Rongjin Sun1, Caixia Yue1, 
Chunlei Zhang1, Yanlei Liu1, Sui Zhou1 & Daxiang Cui1
The development of targeted nanoprobes is a promising approach to cancer diagnostics and therapy. 
In the present work, a novel multifunctional photo/magnet-diagnostic nanoprobe (MNPs-PEG2K-FA@
Ce6) has been developed. This nanoprobe is built using folic acid (FA), bifunctional polyethylene 
glycol (PEG2K) and photosensitizer chlorin e6 (Ce6). The MNPs-PEG2K-FA@Ce6 nanoprobes are 
superparamagnetic, can be synthesized on a large scale by a one-pot hydrothermal process without 
further surface modification and are stable in an aqueous environment for eight months. Compared 
with free Ce6 nanoprobes in vitro studies, the MNPs-PEG2K-FA@Ce6 nanoprobes significantly enhance 
cellular uptake efficiency and promote the effectiveness of photodynamic therapy (PDT) with the 
assistance of 633 nm laser irradiation. The unique nanoprobes show superior penetration and a 
retention time of more than six days with less accumulation in the liver allowing highly effective tumor 
recognition and monitoring. Additionally, there was little damage to healthy organs or tissues. These 
exciting new nanoprobes could be potential building blocks to develop new clinical therapies and 
translational medicine.
In the last few years, gastric tumors have emerged as the secondary cause of cancer-associated mortality glob-
ally1–3, and there has been a significant increase compared to other malignant tumors in China according to the 
latest cancer statistics4. Effective tools for early detection of and therapy for cancer, especially in high-risk individ-
uals, are desperately required for minimizing the morbidity and mortality rates5,6.
Photodynamic therapy (PDT) that employs the singlet oxygen generated by photosensitizer (PS) mole-
cules under light exposure to cause irreversible damage to malignant cells is newly used to cure carcinoma in 
the clinic7. PDT has generated great interest because of its essential merits such as selective, noninvasive and 
repeatable treatment. Unfortunately, there are several significant obstacles for free photosensitizers including 
water-insolubility and poor pharmacokinetics, which have greatly limited the clinical application of PDT therapy. 
Recently, the application of advanced nanotechnology for diagnostics and therapy has attracted great attention8. 
The majority of nanoparticles (NPs) modified by numerous organic and inorganic matters with long circulation 
times have been used as photosensitizer delivery carriers because such agents could efficiently accumulate in 
tumor tissues due to their enhanced permeability and retention (EPR) effects1,9,10. Based on EPR effects, a passive 
targeting strategy of tumors leads to extensive pathophysiological heterogeneity1. Molecular targeting is a type of 
well-established personalized medical method, which relies on exclusively identifying and binding between active 
targeting ligands anchored on the nanoparticle surface and over-expressed folate receptors on the membrane of 
tumor vasculature or tumor cells. FA-mediated Fe3O4 NPs can not only be specifically uptaken by cancer cells, 
but also be used for efficient targeted magnetofluorescent imaging of a gastric cancer mouse model. Dual modal 
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imaging refers to the incorporation of two medical imaging modalities using the same probe, which could pro-
vide better insights into physiological mechanisms at molecular and cellular levels11,12. Recently, a combination 
of magnetic resonance imaging (MRI) and optical imaging platforms for cancer diagnostics and therapy have 
attracted great interest13,14. The noninvasive MRI imaging could provide multidimensional structural, functional 
and morphological information for human/animal soft tissue imaging contrast15, and great advances have been 
achieved for MRI based molecular optical imaging and cell-labeled tracking16,17. Similarly, unparalleled structural 
detail can be achieved by fluorescent imaging, which is attributed to photosensitizer molecules. It is useful to 
combine MRI and fluorescent imaging into a synergistic imaging tool for precisely visualizing and demarcating 
structural/functional details before PDT treatment11,18. Based on targeted NPs and integration of diagnosis and 
treatment system, there will be more useful and viable approaches to fight cancer19,20.
In our previous work, we applied some multifunctional diagnosis platforms using single photosensitizer- 
conjugated/loaded magnetic nanoparticles14 or gold nanoclusters21 for fluorescence imaging to monitor in real 
time and guide photodynamic therapy (PDT). Targeting and tracking gastric cancer cells in vivo is realized by 
labelling fluorescent magnetic nanoparticles (MNPs) with marrow mesenchymal stem cells22. Although some 
progress has been made, there are still many challenging problems including the nanoprobes’ safety and targeted 
tumor efficiency while not leading to significant accumulation in the liver or spleen. Therefore, minimizing the 
accumulation amounts of nanoprobes in the liver or spleen while ensuring effective targeted imaging is a great 
interest for clinical application of early diagnosis of gastric cancer.
Herein, we have developed a facile one-pot hydrothermal route for large-scale synthesis of highly stable 
superparamagnetic Fe3O4 nanoparticles (7.15 ± 1.3 nm in diameter) containing carboxyl groups which do not 
require further surface modification. Next, the Fe3O4 nanoparticles, polyethylene glycol (PEG2K)-coated, and 
folic acid (FA)-functionalized nanoprobes were incorporated with the photosensitizer of chlorin e6 (Ce6) to 
ultimately yield the MNPs-PEG2K-FA@Ce6 nanoprobes. The schematic is shown in Fig. 1. The introduction of 
flexible PEG2K can enhance cell surface recognition, reduce the nanoparticles agglomeration and protein adsorp-
tion, extend circulation time and improve the efficiency of targeting and internalization in vivo23. Human gastric 
carcinoma MGC-803 cells and normal gastric epithelial cells (GES-1) were used in the experiments. MRI and 
fluorescent dual mode imaging were carried out in order to evaluate the synthesized MNPs-PEG2K-FA@Ce6 
targeted nanoprobes and explore the potential for future clinical applications. Our results demonstrated that the 
synthesized MNPs-PEG2K-FA@Ce6 nanoprobes are effective for in vivo targeting, lead to less accumulation in the 
liver while having superior penetration and longer retention time in naive female nude mice.
Material and Methods
Materials. Ferric citrate, FeSO4·7H2O, Folic acid (FA), acetone and tetrahydrofuran (THF) were supplied by 
Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Ascorbic acid (AA), N-hydroxysuccinimide (NHS), 
chlorin e6 (Ce6) and 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) were from Aladdin 
Chemical Reagent Co., Ltd. (Shanghai, China). Amine-PEG2K-Amine (H2N-PEG2K-NH2, MW≈ 2K) was obtained 
from Shanghai XiBao Biotechnology Co., Ltd. (Shanghai, China). 3-[4,5-dimethylthiazol-2-yl]-2,5-diphen-
yltetrazolium bromide (MTT) and Hoechst 33342 were from Sigma-Aldrich Chemical Co., Ltd. (St Louis, MO). 
MGC-803 cells and GES-1 cells were kindly provided by Chinese Academy of Science. Unless otherwise stated, 
all cell culture medium were purchased from GIBCO (Shanghai, China). The water used in all experiments was 
ultrapure water, which was purified using a Milli-Q Water System (18.2 MΩ cm, Millipore Co., USA).
Synthesis of MNPs-COOH. Typically, a FeSO4·7H2O solution was mixed with ferric citrate solution in the 
molar ratio of 2:1. After intense sonication for 10 min, 0.1 g ascorbic acid (AA) was added to the mixture, and the 
Figure 1. Schematic of MNPs-PEG2K-FA@Ce6 nanoprobes for in vitro/vivo imaging. 
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pH was adjusted to 10 using 0.4 M NaOH solution after which the mixture was vigorously stirred for 20 min with 
a magnetic apparatus. After that, the black/green precursors were transferred into a 50 mL capacity Teflon-lined 
autoclave, sealed tightly and raised to 200 °C at a rate of 1.5 °C/min, then kept at 200 °C for 10 h. After the autoclave 
cooled to room temperature, the products were purified using Amico Ultra Centrifugal Filters (MWCO 10 kDa; 
Millipore) in a swing bucket rotor at 11300 rpm for five minutes, washed several times to remove salt and/or 
other by-products. Finally, the black products were dissolved using 50 mL ultrapure water, and then kept at 4 °C 
in refrigerator for later use.
Synthesis of activated FA. NHS-activated FA (FA-NHS) was prepared according to a reported proce-
dure24. In brief, 1.5 g FA was dissolved in a mixture of TEA (0.6 mL) and DMSO (50 mL) at 45 °C with mild stir-
ring. To the resulting solution, 0.52 g DCC and 0.55 g NHS were added orderly, and the mixture was stirred for 
20 h in the dark at room temperature. The products were purified via filtration of reaction mixture, and insoluble 
dicyclohexylurea was removed through a glass wool plug. The filtrate was washed four times with diethyl ether/
acetone and then the precipitates were collected via centrifugation. The freeze-dried pellet was stored at − 20 °C 
in the freezer for later use.
Synthesis of MNPs-PEG2K-FA@Ce6. MNPs were reacted with NH2-PEG2K-NH2 and FA by an EDC/NHS 
coupling reaction to form the MNPs-PEG2K-NH2 and MNPs-PEG2K-FA. A typical reaction of NHS-activated 
MNPs (MNPs-NHS) was as follows: EDC (16 mg) and NHS (20 mg) were sequentially added to 2 mL MNPs 
in MES solution (keeping the solution at pH 5.0) and the reaction components were mixed well and left to 
react at room temperature for 30 min to activate the carboxyl group of MNPs. The MNPs-NHS was washed 
four times using tetrahydrofuran by repeatedly resuspending the suspension and then collecting the products 
using high speed centrifugation. The collected pellet was re-dissolved with 2 mL borate saline buffer solution 
(keeping the solution at pH 7.2). MNPs-PEG2K-NH2 was prepared. Following the previous steps, 12 mg PEG2K 
(Amine-PEG2K-Amine, MW≈ 2000) was quickly added to 2 mL of MNPs-NHS solution by vigorously stirring 
for 12 h at room temperature. After the end of reaction, the products were dissolved using a similar purification 
procedure as the previous method. MNPs-PEG2K-FA was prepared in BS solution. Under the same reaction con-
ditions, 4 mg FA-NHS was dissolved in 2 mL of MNPs-PEG2K solution followed by constant stirring for 20 h. It 
was purified using an Amicon Ultra Centrifugal Filters with an MWCO of 10 kDa and washed four times with 
PBS solution (pH = 7.4) to remove unconjugated folic acid. In order to incorporate the Ce6 molecules, 2 mg Ce6 
dissolved in 1 mL of 0.1 M NaHCO3 was mixed with 8 mg MNPs-PEG2K-FA with 5 mL of 0.1 M NaHCO3 in a 
shaking bed at room temperature overnight. Thereafter, the reaction products were concentrated with an MWCO 
10 kDa of Amico Ultra Centrifugal Filters. The filtrates were collected to calculate the loading amount of Ce6 
molecules. The collected pellet was re-dissolved in 500 μ L of PBS solution.
Characterization of MNPs and MNPs-PEG2K-FA@Ce6. The morphologies of the MNPs and hybrid 
nanoprobes were observed using TEM with a JEM-2100F (JEOL, Japan). The crystalline compositions of the 
as-prepared MNPs were characterized by an X-ray diffractometer with Cu Kα radiation ( λ = 0.15418 nm) at 
a 2θ scan range of 20–70° and a scanning rate of 10 degrees per min (D8 ADVANCE, BRUKER-AXS). Thermal 
gravimetric analysis (TGA/DSC) was measured using a Pyris 1TGA (Perkin Elmer, America) in N2 atmosphere 
at a heating rate of 20 °C/min. The number of carboxyl groups on the MNPs were measured via digital conduc-
tivity instrument (ULTRAMETER II TM 4P, Myron L Company, USA). UV–vis spectra of MNPs, MNPs–PEG2K, 
MNPs-PEG2K-FA, free Ce6 and MNPs-PEG2K-FA@Ce6 were recorded on a Varian Cary 50 spectrophotometer 
(Varian Inc., Palo Alto, CA, USA). Fluorescence spectra (PL) of MNPs, free Ce6 and MNPs-PEG2K-FA@ Ce6 
samples were measured with a Hitachi FL-4600 spectrofluorometer. Fourier transform infrared (FTIR) spec-
tra were performed using a Nicolet 6700 FTIR spectrometer using KBr-supported pellets (Thermo Electron 
Corporation, Madison, WI, USA). Magnetization loops were done by a Physical Property Measurement System 
(PPMS) EverCool-II with 9 Tesla magnets (Quantum Design, USA). The T2 relaxation times of progressive con-
centration of the two samples were obtained by using a 1.4 T Bruker Minispec Analyzer (MQ60). In brief, the 
various concentration of contrast agent (200 μ L, ultrapure water medium) were shifted in dedicated sample tubes, 
and immersed in a 37 °C circulating water bath pot to remain constant. Subsequently, the r2 value (mM-1 s-1) of 
MNPs and MNPs-PEG2K-FA@Ce6 NPs was received by the fitting of T2 value corresponded to the serial concen-
tration (mM) plots, the slope of the optimum fitting straight, namely.
Drug loading and release efficiency measurements. The theoretical drug loading percentage was cal-
culated according to the equation 1:
= −
×
DrugLoadingEfficiency(%) (totaldrugcontent drug incollectedfiltrate)/
(totalamountofdrugused) 100% (1)
The release of Ce6 from MNPs-PEG2K-FA@Ce6 was measured with UV-Vis spectroscopy placed in shaking 
reactor at 37 °C in PBS buffer (pH = 7.4), using a slightly modified procedure from that previously reported22. In 
brief, the 2 mL of MNPs-PEG2K-FA@Ce6 dispersion (16 mg mL−1) was put into a dialysis tube (MWCO 3500) 
and dipped in 50 mL of the PBS media with constant shaking (400 rpm) at 37 °C. At pre-set times, 2 mL release 
solution was transferred for UV–vis detection and compensated with similar volume of fresh solution.
Cell Culture and Cytotoxicity Assay. The MGC-803 and GES-1 cells were regularly cultured in 25 cm2 
plates at 37 °C in a humidified incubator with 5% CO2, immersed in 8 mL of Dulbecco’s Modified Eagle’s Medium 
(DMEM) containing 10% (vol/vol) heat-inactivated fetal bovine serum (FBS), penicillin (100 U mL−1) and 
streptomycin (100 μ g mL−1). Then, the photo-therapeutic efficacy in vitro of hybrid nanoprobe was checked 
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by an MTT viability assay of MGC-803 cells. Briefly, 5 × 103 cells were seeded in 96-well plate to adhere the 
cells. After a 12 h incubation, the medium was discarded instead of 100 μ L fresh medium such as PBS (con-
trol group), cell culture fluid containing different concentrations of MNPs (with final concentration of 5–100 μ 
g mL−1) and MNPs-PEG2K-FA@Ce6 was added. Subsequently, the cells were washed twice using fresh medium 
after co-incubation 12 h. Then, each hole in 96-well plate was irradiated using or not using 633 nm helium-neon 
(He-Ne) laser at a maximum power of 50 mW/cm2 for 1 min to examine phototoxicity and dark toxicity of free 
Ce6 and MNPs-PEG2K-FA@Ce6. After 24 h incubation under common conditions, MTT solution was put into 
each well and the MGC-803 cells and GES-1 cells were cultured for additional 4 h. After that, 100 μ L of DMSO 
was used to dissolve the solid formazan crystals. The optical density (OD) value of per well was tested using a 
Multiskan mircoplate reader (Thermo Scientific, Thermo MK3) at 570 nm. The average and standard deviation 
(SD) of six parallel wells for each concentration were reported.
Cellular uptake in vitro. To observe the specific uptake of the nanoprobe, both MGC-803 and GES-1 cells 
were respectively seeded into 4-chamber glass bottom dish to adhere the cells. After overnight incubation, using 
the free Ce6 (10 μ g mL−1) and MNPs-PEG2K-FA@Ce6 (equivalent Ce6 10 μ g mL−1) solution repeatedly, the adher-
ent cells were adequately rinsed using PBS and fixed with paraformaldehyde (4%) for 20 min at 4 °C in a refrig-
erator. The nuclei of the cells were counterstained according to a standard procedure of Hochest (1 mg mL−1) 
for 20 min. The fluorescence signal of free Ce6 and the fluorescent nanoprobes in cells were also examined. The 
emission was separately collected through either 420–460 nm or 650–700 nm barrier filter. The targeting spec-
ificity of the nanoprobes to MGC-803 cells was recorded using flow cytometry by monitoring the fluorescence 
signal in FL3-H (λ em = 650–700 nm) channel. Both MGC-803 and GES-1cells were cultured overnight in 12-well 
plates at a density of 5.0 × 104 cells per well. Then the cells were coincubated using free Ce6 or MNPs-PEG2K-FA@
Ce6 for various times. Finally, the adherent cells were rinsed twice using PBS, and then trypsinized, centrifuged, 
re-suspended in PBS solution and recorded by flow cytometer.
Animal model loaded with gastric cancer. Animal procedures were carried out in accordance with 
the relevant guidelines and regulations approved by institutional animal use, care and ethics committee. Female 
nude mice (20–22 g weight) were obtained from SLAC Laboratory Animal center (Shanghai, China). Animals 
were raised five in each cage at 22 ± 2 °C, fed a normal diet and water, and kept in animal care protocols under 
pathogen-free conditions. The life sciences committees of Shanghai Jiao Tong University approved the experi-
ments, and all animal procedures were in agreement with institutional animal use and care regulations. About 
4 weeks later, an animal tumor model (10–15 mm in diameter) was established by subcutaneously inject-
ing 5 × 106 MGC-803 cells resuspended in PBS solution (0.1 mL) on the right hind leg area of each nude mice 
(6 weeks old).
In vitro/vivo fluorescent imaging and MR imaging. After intravenous injection of MNPs-PEG2K-FA@
Ce6 (10 μ g mL−1 Ce6) by the tail vein, the real-time in vivo optical imaging was carried out by the Signa HDx (GE 
medical systems, U.S.). All in vitro/vivo MR scanning were carried out with a 3.0 T Siemens Magnetom Trio med-
ical MR systems (Shanghai sixth people’s hospital radiology department of MRI, Shanghai, China) with the fol-
lowing parameters: TR = 2600 ms, slice thickness = 2 mm, TE = 52 ms, matrix = 320 × 256, FOV = 1 cm × 1 cm, 
NEX = 2, and acquisition time 96 s. The gray values of both MGC-803 and GES-1 cells at varying Fe concentra-
tions (0.16, 0.32, 0.64, 1.28 and 2.56 mM, respectively) were performed using a clinical MR system and obtained 
with MR imaging software. The nude mice were anesthetized, placed inside a receiver coil and scanned after 
post-injection 12 h and 15 h of MNPs or MNPs-PEG2K-FA@Ce6.
Photodynamic therapy of gastric cancer in vivo. Right-hand MGC-803 subcutaneous xenografted 
tumor models were used to estimate the effect of photodynamic therapy in vivo. Firstly, the experiment mice were 
randomly divided into five groups of five mice/group, when the size of tumor reached ~100 mm3. Briefly, (1) PBS 
(100 μ L) with laser (control group), (2) free Ce6 (5 mg/kg), (3) free Ce6 (5 mg/kg) combined with laser irradi-
ation, (4) MNPs-PEG-FA@Ce6 (doses equivalent to 5 mg/kg of Ce6), (5) MNPs-PEG2K-FA@Ce6 (doses equiv-
alent to 5 mg/kg of Ce6) upon laser irradiation were respectively injected by caudal vein. In exposure groups, a 
633 nm He-Ne laser was used with 50 mW/cm2 for 30 min after 10 and 24 h post-injection. Then, the tumor size 
and body weight of each rat were measured every 3 days after treatment until 18 days. At day 18, rats treated 
with MNPs-PEG2K-FA@Ce6/laser were sacrificed. The major organs and tissues (liver, spleen, lungs, kidneys 
and heart) collected from gastric tumor-bearing mice at day 18 after injection in MNPs-PEG2K-FA@Ce6/laser 
treatment group were sliced, stained with hematoxylin and eosin (H&E) as routine, then morphological charac-
teristics of each organ tissue were observed with microscopy.
Results and Discussion
Synthesis and characterization of MNPs. The TEM image (Fig. 2a) shows that the Fe3O4 nanoparticles 
were uniform in size and have a spherical structure with a diameter of about 7.15 ± 1.3 nm (Figure SI1). The 
thermal stability and decomposition behavior of MNPs were evaluated by thermo-gravimetric analysis (TGA) 
in a nitrogen atmosphere, as shown in Fig. 2b. The weight loss from 100 to 400 °C corresponds to the removal of 
the unstable oxygen-containing groups from the organic species. The further weight loss in the range of 467 to 
750 °C was related to the removal of the relatively stable oxygen-containing groups. When the temperature is over 
750 °C, the oxygen-containing groups on the surface of Fe3O4 are completely removed. The total weight loss of 
16.7% reveals that the surface of the synthesized Fe3O4 nanoparticles has large numbers of carboxyl groups. The 
amount of carboxyl groups on the surface of Fe3O4 nanoparticles, obtained from the conductometric titration 
curve (Figure SI2), is 0.73 mmol/g (more details in Supporting information)25,26. The synthesized brownish black 
products were dried and characterized through X-ray power diffraction (XRD). The XRD pattern (Fig. 2c) of the 
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samples is consistent with that of the standard cubic Fe3O4 structure (JCPDS no.19-0629). Based on the strongest 
peak (311), the size of nanoparticles is 7.85 nm according to the Scherrer formula, which is in agreement with the 
TEM data. It is interesting to observe that the synthesized MNPs exhibited excellent water dispersibility. Eight 
months after the initial synthesis, there were no precipitates at the bottom of the bottle (Fig. 2d).
The hydrodynamic sizes of MNPs, MNPs-PEG2K, MNPs-PEG2K-FA, MNPs-PEG2K-FA@Ce6 dissolved 
in ultrapure water were measured to be 39.3 nm, 54.7 nm, 75.5 nm and 72 nm respectively as determined by 
dynamic light scattering (DLS). In addition, the Zeta-potential of MNPs, MNPs-PEG2K, MNPs-PEG2K-FA, 
MNPs-PEG2K-FA@Ce6 dispersed in ultrapure water were measured to be − 3.59 mV, 3.46 mV, − 0.95 mV and − 
3.37 mV. To estimate the stability of the MNPs and MNPs-PEG2K-FA@Ce6 nanoprobes, they were dispersed in PBS 
with a pH of 7.4. It was shown that the systems were stable and that there was no aggregation after 1 d (Figure SI3). 
The hydrodynamic sizes of MNPs and MNPs-PEG2K-FA@Ce6 in PBS were measured to be 30.3 nm and 159.8 nm, 
which was significantly smaller than the iron oxide nanoprobes reported previously27. The TEM image of Fig. 3a 
shows the MNPs-PEG2K-FA@Ce6 nanoprobes are highly dispersed. Figure 3b shows the distinct and successive 
lattice-fringe images, indicating the perfect single-crystal of Fe3O4. The fringe space between adjacent fringes 
is measured to be 0.485 nm, which is close to the (111) crystalline plane of Fe3O4. In order to improve the bio-
compatibility and loading of the fluorescent dye (Ce6), NH2-PEG2K-NH2 was used to modify the nanoparticle 
surface. The thickness of coating layer was about 1.5 nm (Fig. 3c). Figure 3d showed that MNPs-PEG2K-FA@Ce6 
nanoprobes exhibit superparamagnetic properties. The saturation magnetization value (Ms) of the nanoprobes 
is observed to be 30.6 emu g−1. These results show that the prepared MNPs-PEG2K-FA@Ce6 are small and can be 
applied in MRI for clinical diagnosis28.
Formation and characterization of MNPs-PEG 2K-FA @Ce6 nanoprobes. On the basis of the 
stability of as-synthesized MNPs dispersed in aqueous solution, the highly stable intermediate products of 
MNPs-PEG2K-FA were formed, and then the drug (Ce6) was embedded within PEG2K network. The Ce6 mole-
cules were stable in the intermediate products due to hydrophobic interactions between nonpolar segment of Ce6 
and PEG2K chains21. The loading capacity of Ce6 molecules in the intermediate products was about 10.16 wt%, 
based on UV-Vis spectroscopy analysis. Owing to the resonance energy transfer, the fluorescence of nanoprobes 
was partially quenched (Fig. 4a). Figure 4b is the absorption spectra of MNPs, MNPs-PEG2K, MNPs-PEG2K-FA, 
free Ce6 and MNPs-PEG2K-FA@Ce6 in PBS. The Curve b in Fig. 4b shows the characteristic peak which has 
a slightly blue-shift to 276 nm after PEG2K was conjugated to the MNPs, compared with PEG2K (characteristic 
absorption peak around 283 nm). It may be attributed to the change of polarization rate of molecule? Particularly, 
there are two wide distinct peaks at 350 nm and a sharp peak at 283 nm, which are the characteristic absorption 
peaks of FA in the MNPs-PEG2K-FA and MNPs-PEG2K-FA@Ce629. Importantly, it was shown that there is a 
pronounced red shift in the absorption from 645 nm (curve d in Fig. 4b) to 654 nm (curve e in Fig. 4b) in the 
region of Ce6 Q(I) band, which was a typical response of Ce6 in different chemical environment21. Interestingly, 
Figure 2. Characterization of the as-formed MNPs (a) TEM image, (b) TGA analysis, (c) XRD pattern, (d) 
visual image of Fe3O4 nanoparticles dispersed in ultrapure water.
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the spectra of Ce6 (sample d) in Fig. 4b also had a little sharp peak around 283 nm. It may be caused by contain-
ing the carbonyl group as chromophore, which was possibly attributed to n electronic transition of impurity 
atoms on unsaturated bond into П* orbit30. However, it belongs to the weak absorption band, as shown a little 
sharp peak. FTIR spectral measurements showed that the components of the nanoprobes such as FA, PEG2K 
and Ce6 were combined with the MNPs as expected (Figure SI4). The FTIR shows that the PEG2K is bound to 
the MNPs by the formation of an amide with the vibrations for the amide bond observed at 1647 cm−1 (C=O) 
and 1533 cm−1 (N–H). The peak at 1108 cm−1 (C–O–C), 2851 and 2919 cm−1 (–CH2–) indicated the existence of 
PEG2K. Additionally, the peak at 1604 cm−1 is the characteristic absorption peak of amino group from pteridine 
ring of FA, suggesting the successful chemical coupling of MNPs-PEG2K and FA. The small particle size results 
in the superparamagnetic behaviour31. The membrane surface of GES-1 cells without FA over-expression recep-
tor were as control group. After incubation for 12 h with the MNPs-PEG2K-FA@Ce6 nanoprobes at different Fe 
concentrations, the MGC-803 and GES-1 cells were subjected in 1 × PBS to T2-weighted MR imaging at room 
temperature (Fig. 4d,e). It was shown that the gray value of both GES-1 and MGC-803 cells reduced with increas-
ing Fe concentration. Apparently, the reducing trend of MGC-803 cells was much more than that of GES-1 cells 
under the same experimental conditions (Fig. 4d). To further prove T2 signal enhancement effect following the 
increase of the Fe concentration (Fig. 4c), quantitative statistics of the gray value are shown in Fig. 4e, suggesting 
the feasibility of the synthesized hybrid nanoprobes for medical diagnosis.
Cellular Uptake Assay. Various samples with and without FA ligands were used to interact with gastric 
cancer MGC-803 cells and GES-1 cells. Both the confocal laser scanning microscopy (CLSM) and flow cytom-
etry (FCM) were carried out to evaluate their targeted effectiveness in Fig. 5. The fluorescence intensity of the 
MGC-803 cells incubated with MNPs-PEG2K-FA@Ce6 (equivalent Ce6) and free Ce6 was monitored for 10 h. 
With increasing incubation time, the MNPs-PEG2K-FA@Ce6 were taken up much more dramatically than free 
Ce6 in the MGC-803 cells (Fig. 5a). After a half an hour incubation, the fluorescence signals of the cells that had 
interacted with the MNPs-PEG2K-FA@Ce6 were brighter than with free Ce6, suggesting much more Ce6 has 
been endocytosed into the cells. Furthermore, the fluorescent distribution was very uniform in the cytoplasm and 
cytomembrane. This result was also confirmed by the quantitative analysis of fluorescence intensity by FCM. The 
median values of the fluorescence intensity for the cells incubated with the nanoprobes at 0.5 h was about 1.4-fold, 
compared with control group (free Ce6) in Fig. 5b. After 10 h of successive incubation, the different quantity of 
phagocytosis between MNPs-PEG2K-FA@Ce6 and free Ce6 was most significant, and then the median values of 
the fluorescence intensity was about 4.3-fold higher. To further evaluate the specific targeting of the nanoprobes, 
Figure 3. Characterization of the MNPs-PEG2K-FA@Ce6 nanoprobes. (a) TEM image, (b,c) HRTEM 
pattern, (d) magnetization loops measured at 300 K.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:36187 | DOI: 10.1038/srep36187
we chose FR-negative cells such as GES-1 cells to assess the interaction of the cells and the nanoprobes as another 
control group in Figure SI5. It was shown that the fluorescence intensity of GES-1 cells incubated with free Ce6 
increased remarkably from 4 h to 10 h. However, the weaker red fluorescence signal was displayed even after 10 h 
the GES-1 cells incubated with the nanoprobes, compared with interaction effect for MGC-803. These results 
were due to over-expression of membrane folate receptors such as MGC-803 cells.
In Vitro Cellular Toxicity. To evaluate the photocytotoxicity of free Ce6 and the nanoprobes under the laser 
irradiation (λ ex = 633 nm), MTT assay and fluorescence microscopy were carried out respectively. Figure 6 and 
Figure SI8 indicated that the MNPs-PEG2K-FA@Ce6 nanoprobes had the best biocompatibility and non-toxicity 
toward the MGC-803 cells and GES-1 cells in the absence of laser irradiation by MTT assay. However, it was 
worth noting that the MGC-803 cell death ratios caused by the nanoprobes (10 μ g/ml of Ce6 equiv) under the 
laser irradiation were about 1.5-fold higher than control group (10 μ g/ml of free Ce6), while GES-1 cell death 
ratios were about 1.3-fold higher than control group. The prominent photocytotoxicity of the MNPs-PEG2K-FA@
Ce6 could be attributed to the increase of cellular uptake, and subsequently generate much more reactive oxygen 
species (ROS) (Figure SI6). Figure SI7 demonstrates the non-toxicity of MNPs-based nanoprobes without the 
laser irradiation. The amount of drug released is shown in Figures SI9 and SI10 reaching a release of about 30% 
after 6 h. The hydrophobic Ce6 molecule loaded into nanoprobes showed excellent stability and biocompatibility, 
indicating great potential as feasible nanoprobes for PDT treatment in vivo. These results were consistent with the 
detection of photodamage by fluorescence microscopy (Figure SI11).
In vivo fluorescent imaging and MR imaging. To evaluate tumor specific targeting property of 
MNPs-PEG2K-FA@Ce6 nanoprobes, the whole-body optical imaging system was applied to monitor the intrinsic 
NIR fluorescence signal of Ce6 released by the nanoprobes. About three weeks after MGC-803 cells injection, the 
size of tumor nodules was to 50–80 mm3. Free Ce6 (10 μ g/mL, 100 μ L) and MNPs-PEG2K-FA@Ce6 nanoprobes 
(equivalent Ce6 concentration) were intravenously injected in nude mice for real-time detection of the distribu-
tion in vivo of the drug. Figure SI12 showed that strong fluorescence was mainly present in the liver using free 
Ce6-treated mice. However, the signal in the tumor tissue was relatively weak because of the absence of tumor 
specific targeting. Additionally, the fluorescence signal in mice decreased rapidly at 24 h post-injection attributed 
to the small size and poor pharmacokinetics of Ce6 micromolecule. Nevertheless, we also observed a distribution 
Figure 4. Characterization of the MNPs-PEG2K-FA@Ce6 nanoprobes. (a) PL spectra, (b) UV− Vis 
absorption. (a. MNPs, b. MNPs-PEG2K, c. MNPs-PEG2K-FA, d. Ce6, and e. MNPs-PEG2K-FA @Ce6), (Insets) 
Digital pictures of PBS, MNPs, free Ce6, and MNPs-PEG2K-FA@Ce6 dispersed in PBS solution (the left of 
photograph was under white-light, and the right of one was under UV (365 nm) excitation), (c) the value of T2 
relaxation rate of MNPs and MNPs-PEG2K-FA@Ce6 NPs under various Fe concentration, (d) the T2-weighted 
MR images of MNPs-PEG2K-FA@Ce6 nanoprobes under various Fe concentration and (e) the gray value in 
GES-1 and MGC-803 cells.
www.nature.com/scientificreports/
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Figure 5. (a) Confocal images showing relationship between MGC-803 cells and free Ce6 and MNPs-PEG2K-FA@ 
Ce6 for 0.5, 4, and 10 h. (Note that: Each block diagram is composed of four small squares. The blue areas in top 
left of four small squares shows the nucleus of fluorescent images; lower left image was fluorescent images about 
cellular uptake of MNPs-PEG2K-FA@Ce6 or free Ce6 in red field; top right images are of MGC-803 cells in light 
field; lower right are merge images of the other three small squares). The scale bar was 100 μ m. (b) Flow cytometry 
graphs showing significant variation of cellular uptake between targeted nanoprobes and no-targeted nanoprobes. 
Red, cyan and orange curves represent interactions of PBS, free Ce6 and MNPs-PEG2K-FA@Ce6 with MGC-803 
cells, respectively. (In median: X/Y, X was representative for the amounts of cellular uptake of control group, and Y 
was representative for the amounts of cellular uptake of MNPs-PEG2K-FA@Ce6 nanoprobes).
Figure 6. The toxicity analysis in the dark (a) and under the laser irradiation (λ ex = 633 nm) (b) of free Ce6 and 
MNPs-PEG2K -FA @ Ce6 incubation with MGC-803 cells.
www.nature.com/scientificreports/
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Figure 7. (a) Representative fluorescence images of tumor-bearing mouse after injection with MNPs-
PEG2K-FA@Ce6 by real-time observation for 6 d. (b) Ex vivo fluorescence imaging of major organs and tumors 
of mice dissected at 24 h post-injection of free Ce6 and MNPs-PEG2K-FA@Ce6. The letters H, Lu, Li, K, S and T 
stand for heart, lung, liver, kidney, spleen and tumor respectively. (c) The quantitative fluorescent analysis of the 
dissected organs and tumors of mice after tail vein injection of 24 h.
Figure 8. In vivo MRI. (a) MR images acquired at 12 h and 15 h - post injection of MNPs and MNPs-
PEG2K-FA@Ce6 under the T2-weighted. (Note that: White circles and arrows indicate tumors in the presence 
of MNPs and targeted nanoprobes, respectively. These numbers respect T2-weighted mean signal intensity). 
(b) Representative Prussian Blue staining images of tumor cryosections (10 μ m) at 12 h post-injection. Images 
presented are blank, MNPs and MNPs-PEG2K-FA@ Ce6 nanoprobes.
www.nature.com/scientificreports/
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of strong fluorescent signal in the liver and lungs at 12 h post-injection, higher tumor targeting was displayed for 
the MNPs-PEG2K-FA@Ce6 nanoprobes injected into the mice. The enhanced fluorescent intensity in tumor was 
sustainable for 24 h, fully proving that MNPs-PEG2K-FA@Ce6 nanoprobes were not rapidly eliminated from the 
body. With increasing time, the fluorescent intensity of the tumor areas became more distinct at 1 d post-injection 
due to the nanoprobes accumulation in the tumors, but meanwhile the fluorescence background of other organs 
had weakened. Interestingly, a fluorescent signal was almost undetected in liver tissue after two days. Figure 7a 
showed that the fluorescent signal in the tumor lasted for more than 6 d, indicating that MNPs-PEG2K-FA@Ce6 
nanoprobes had the relatively very long tumor retention time attributed to active targeting and EPR effect. We 
speculate that an acidic environment in tumor can promote the corrosion of the Fe3O4 cores of nanoprobes, lead-
ing to the release of drug molecules32–34. So it confirmed that there was gradually specific release of Ce6 in tumor. 
The corrosion behaviour could result in removal and dissociation of the partial PEG2K coating. The degradation 
of the organic coating could be similar to proteolytic digestion33. In particular, high tumor targeting efficiency of 
MNPs-PEG2K-FA@Ce6 nanoprobes was also vividly indicated via fluorescence images of isolated viscus at 24 h 
post-injection (Fig. 7b,c). As shown in Fig. 7c, although certain MNPs-PEG2K-FA@Ce6 nanoprobes appeared in 
normal tissues including heart, liver, spleen and so on at 24 h post-injection, there would be almost no toxicity of 
MNPs-PEG2K-FA@Ce6 nanoprobes for normal organs without NIR laser irradiation.
Figure 9. In vivo photodynamic therapy of MNPs-PEG2K-FA@Ce6. (a) The optical photograph of different 
groups before and after treatments. The solid tumor sites of tumor-bearing mice respectively treated using PBS, 
free Ce6 and MNPs-PEG2K-FA@Ce6 were irradiated with 633 nm laser (50 mW/cm2) for 30 min after 4 and 24 h 
post-injection. (b) MGC-803 tumor growth curves of different groups after treatments. The data are shown as 
mean ± SD (n = 5).
Figure 10. No noteworthy sign of toxic side effect of MNPs-PEG2K-FA@Ce6/laser in vivo. (a) Time-
independent body weight curves of mice after various treatments. The data are shown as mean ± SD (n = 5).  
(b) H&E stained tissue sections of major organs including liver, spleen, lungs, kidneys and heart of the mice 
treated with MNPs-PEG2K-FA@Ce6/laser after day 18. Scale bar, 100 μ m.
www.nature.com/scientificreports/
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To further investigate the use of MNPs-PEG2K-FA@Ce6 as an effective imaging reagent, MRI was carried out 
at 12 h and 15 h after intravenous injection of the nanoprobes (Fig. 8a). Notably, after 12 h and 15 h post-injection 
the MNPs or the MNPs-PEG2K-FA@Ce6, the MR signal in the tumor mass displayed darker than that of blank 
control group. With the injection of the no-targeted MNPs, the signal value gradually increases from 69.1% (12 h) 
to 76.9% (15 h). In comparison, the signal value of the tumor injected with the targeted Fe3O4-PEG2K-FA@Ce6 
nanoprobes gradually decreases from 62.9% (12 h) to 58.2% (15 h). Most importantly, compared to no-targeted 
MNPs, the T2-MR images at 12 h post-injection of the targeted MNPs-PEG2K-FA@Ce6 nanoprobe appeared 
to be more homogenously distributed in the tumor region (Fig. 8b), which implies that the FA-modified 
MNPs-PEG2K-FA@Ce6 nanoprobes can particularly target the overexpression of membrane folate receptors 
according to a receptor-mediated manner and have relatively long tumor retention time, consistent with the 
fluorescence imaging results. This result indicates that PEG coatings and FA ligands were introduced to slow 
down protein adsorption and nanoparticle aggregation, thus increasing the nanoparticle biocompatibility and 
promoting their internalization acting on targeted tumor, thus contributed to efficient photodynamic therapy.
Photodynamic therapeutic efficacy of MNPs-PEG2K-FA@Ce6 in vivo. To evaluate the photody-
namic therapeutic efficacy of MNPs-PEG2K-FA@Ce6 in vivo, the changes of tumors in volume were inspected 
over 18 days. After 4 and 24 h post-injection, the solid tumor sites of tumor-bearing mice respectively treated 
using PBS, free Ce6 and MNPs-PEG2K-FA@Ce6 were irradiated with 633 nm laser (50 mW/cm2) for 30 min, 
separately. As shown in Fig. 9, compared with normal group, the growth of MGC-803 tumors treated with 
MNPs-PEG2K-FA@Ce6/laser in mice was significantly inhibited by ~69%, illustrating the effectiveness of the 
photodynamic therapy. In control group, mice receiving free Ce6 plus laser treatment showed ~46% tumor 
growth inhibition. While the growth inhibition of tumor on mice treated with free Ce6 without laser and 
MNPs-PEG2K-FA@Ce6 without laser showed merely below 5%. It may be due to the long tumor residence time 
and selective tumor-targeting capabilities of MNPs-PEG2K-FA@Ce6 nanoprobes.
To confirm and investigate the potential toxicity of MNPs-PEG2K-FA@Ce6 in mice, the changes of 
tumor-bearing mice in weight were monitored as an indicator of poisonous side effect measurement. As shown 
in Fig. 10a, no noticeable change in mice weight was observed in five groups. At day 18, the major organs and 
tissues (liver, spleen, lungs, kidneys, heart and brain) collected after injection in MNPs-PEG2K-FA@Ce6/laser 
treatment group were sliced, stained with hematoxylin and eosin (H&E) with the standard protocol, then it was 
observed with microscopy. Notably, no pathological abnormalities or other conditions were observed by histo-
logical examination of major organs tissues in our experiments (Fig. 10b). Clearly, no noteworthy sign of toxic 
side effect of MNPs-PEG2K-FA@Ce6/laser in vivo was observed, as further uncovered by histological examination 
after receiving photodynamic therapy. Considering the less accumulation of MNPs-PEG2K-FA@Ce6 in the liver 
after more than 6 days, it may be logical to conclude that nanoprobes would not lead to significant long-cycle side 
effect in the body.
Conclusions
In conclusion, we have designed a convenient and feasible method for magneto/fluorescent dual-modal imaging 
of gastric cancer by introducing MNPs-PEG2K-FA@Ce6 synthesized in aqueous phase as a contrast agent with 
co-imaging effect. The fluorescence imaging and MR images vividly illustrate the distribution of nanoparticles 
in whole body, especially to determine the uptake quantity in normal tissue and tumor. It is possible not only to 
understand the tumor targeting mechanism of the contrast agent, but also to achieve a comprehensive medical 
diagnosis for the optimized treatment efficacy. Based on these results, the selective targeting of the tumor and 
long residence time of the nanoprobes were dramatically enhanced via MNPs modified by FA ligands and PEG2K. 
More importantly, penetration and retention time of more than 6 days with less accumulation in the liver due 
to the highly stable MNPs-PEG2K-FA@Ce6 nanoprobes was observed, avoiding damage to healthy organs or 
tissues due to drug toxicity. Moreover, under 633 nm laser irradiation, the significant therapeutic effect of these 
nanoprobes were exhibited in vivo. Based on these findings, the contrast agent with co-localization effect could 
be potentially used for tumor recognition and monitoring before and after treatment in clinical medicine, may 
prospectively serve as a novel photodynamic anticancer nanoprobe in the near future.
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